Haemonetics Corp. (HAE)
NYSE:HAE
Holding HAE?
Track your performance easily

Haemonetics (HAE) Financial Statements

390 Followers

Haemonetics Financial Overview

Haemonetics's market cap is currently ―. The company's EPS TTM is $2.232; its P/E ratio is 32.02; Haemonetics is scheduled to report earnings on November 7, 2024, and the estimated EPS forecast is $1.07. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 336.17M$ 343.29M$ 336.25M$ 318.18M$ 311.33M
Gross Profit$ 174.92M$ 175.91M$ 177.87M$ 170.51M$ 167.26M
EBIT$ 46.67M$ 23.18M$ 44.03M$ 32.83M$ 51.59M
EBITDA$ 81.05M$ 54.95M$ 68.34M$ 56.63M$ 75.45M
Net Income Common Stockholders$ 50.88M$ 20.37M$ 31.24M$ 39.40M$ 41.04M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 344.43M$ 178.80M$ 193.98M$ 351.00M$ 285.72M
Total Assets$ 2.54B$ 2.20B$ 2.20B$ 2.01B$ 1.96B
Total Debt$ 1.22B$ 807.79M$ 870.59M$ 762.23M$ 764.95M
Net Debt$ 879.16M$ 628.99M$ 676.61M$ 411.22M$ 479.23M
Total Liabilities$ 1.64B$ 1.24B$ 1.26B$ 1.12B$ 1.10B
Stockholders Equity$ 905.37M$ 959.96M$ 943.32M$ 893.66M$ 864.62M
Cash Flow-
Free Cash Flow$ -12.71M$ 54.95M$ -22.50M$ 72.12M$ 12.70M
Operating Cash Flow$ -27.42M$ 64.08M$ -540.00K$ 96.25M$ 21.96M
Investing Cash Flow$ -139.20M$ -13.06M$ -268.94M$ -25.14M$ -15.26M
Financing Cash Flow$ 333.69M$ -63.50M$ 109.43M$ -4.30M$ -3.47M
Currency in USD

Haemonetics Earnings and Revenue History

Haemonetics Debt to Assets

Haemonetics Cash Flow

Haemonetics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis